Emerging agents for onychomycosis

B. M. Piraccini, M. Iorizzo, G. Rech, A. Tosti

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60% to 80%, and relapses are not rare (up to 20% of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presented.

Original languageEnglish (US)
Pages (from-to)155-159
Number of pages5
JournalGiornale Italiano di Dermatologia e Venereologia
Issue number2
StatePublished - Apr 2006
Externally publishedYes


  • Antimicotics
  • Nails
  • Posaconazole
  • Ravuconazole
  • Voriconazole

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Emerging agents for onychomycosis'. Together they form a unique fingerprint.

Cite this